Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012

Authors: Afif
Agnes V. Klein
Anthony A.G. Ridgway
Anthony S. Lubiniecki
Baert
Bartelds
Bartelds
Boven
Brian G. Feagan
Casadevall
European Medicines Agency Committee for Medicinal Products for Human Use
European Medicines Agency Committee for Medicinal Products for Human Use
European Medicines Agency Committee for Medicinal Products for Human Use
Custodio
Diane R. Mould
Edward C. Keystone
European Medicines Agency
European Medicines Agency
Food and Drug Administration
Food and Drug Administration
Government of Alberta
Hanauer
Health Canada
Health Canada Health Products and Food Branch
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Jian Wang
Jiang
Jonathan Kay
Kapel
Karmiris
Kay
Klein
Kremer
Kwasi A. Nyarko
Lecluse
Maureen E. Trudeau
Micheal S. Guirguis
Mould
Nesbitt
World Health Organization Program on International Nonproprietary Names (INN)
Reichert
Sandborn
Scheinberg
Schellekens
Schiestl
Skibeli
Storring
Wadhwa
Weir
World Health Organization
Xie
Publication date
Publisher: 'Elsevier BV'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1016%2Fj.biologica...

Last time updated on 05/06/2019